Read more about the latest developments in MS research, treatments and specialist care, plus the latest updates on our work and the efforts of our amazing supporters
The MS Trust sends out a weekly news alert which includes the latest updates from the MS Trust, latest news, blogs and a news feed from MS in the Media.
Read our latest news
- SMC approves Ocrevus
- Australian stem cell study
- Switching interferons increases relapse risk
What causes MS? This is something we yet don't know, but there are a lot of theories out there. In this blog guest blogger Emily, takes us through some of them.
The Scottish Medicines Consortium (SMC) has approved Ocrevus (ocrelizumab) as an NHS treatment for relapsing remitting multiple sclerosis in Scotland.
When Katie Silverthorne was diagnosed with MS when she was just 23, she had no idea that her condition would one day spur her on to open her own successful business. In this blog, Katie writes about coming to terms with her MS diagnosis and how it gave her the courage to take a leap of faith and start her own business.
Is there a funny side to MS? We talk to stand-up comedian Will Berard who has MS, about life with the condition, getting diagnosed and raising awareness through comedy.
- Depression affected by lifestyle factors
- Gilenya approved for childhood MS
- Lemtrada warning issued
The European Commission has approved the extension of the licence for Gilenya (fingolimod) to include treatment of children and adolescents 10 years or older with relapsing remitting MS.
- Cognition affects ability to work
- Gender differences in diagnosis
- Rare Gilenya side effect warning
- Fampyra turned down in Scotland
Ben Dorward, lead neurosciences pharmacist at Sheffield Teaching Hospitals NHS Foundation Trust, describes his project - to jointly develop an IT system that links prescription management to blood monitoring and can be accessed by the MS and pharmacy teams.
For many, MS nurses are a lifeline but, sadly, we know that some people are missing out on the vital care and support they provide, simply because there are currently not enough of them. The MS Trust recently published a report into nurse provision across the UK, this blog looks at some of the key findings.
- Heavy caseloads for MS specialist nurses
- Ocrevus slows progression in upper limbs
- Parenting with MS
- Trains and planes and disability
- Vitamin D recommendation
The MS Trust is delighted to announce that South Tees, NHS Lothian, Hull and North Lincs and Goole will be the next areas to benefit from our pioneering Specialist Nurse Programme.
Spencer Bull was the vice-captain of the GB squad at last month’s Invictus Games. Here the British Army Lieutenant Colonel talks to us about “taking back control” following an MS diagnosis.
What do you do when the disease modifying drug (DMD) you've chosen isn't working? In this guest blog, Lauren shares her thoughts around choosing an MS treatment and what it is like having to change to a new one.
The Scottish Medicines Consortium (SMC) has decided that fampridine (Fampyra) will not be made available on the NHS in Scotland for people with MS-related walking problems.
Kate guest blogs about her experiences taking part in a clinical trial for the drug bexarotene.
- The effect of pregnancy on MS
- Ocrevus for PPMS decision paused
- Coexisting conditions affect atrophy
- Medical cannabis rule change in Jersey
Spasticity and spasms are a common symptom of MS and can have a big impact on your daily life. To find out how they can be successfully treated and managed, we put some of your questions to physiotherapist, Katrina Buchanan.
25 years ago, the MS Trust was founded on Christmas card sales and they still play a crucial role today in enabling us to support everyone affected by MS.